Yesterday, April 27, 2015, Florida‘s SB 7066, was postponed again by the Florida Senate, the fifth time in the last five sessions. The general session for the Florida Senate is set to expire at midnight this coming Friday, and there is fear the bill will not pass. The bill has gained approval of cannabis activists in the state, including the Florida Cannabis Action Network. The bill would allow 15 percent THC for qualifying patients, permitting them to get relief of ailment symptoms as well as potentially cure some diseases, as some research is leaning. The bill does not go far enough for libertarians in the State of Florida; however, feel it is a step in the right direction by respecting patients in need of a natural solution to the medical conditions.
Activists are hoping the general public will rise to the occasion to support the bill and send an email to their representatives in support of the SB 7066. There has been a strike-all amendment added that, with its amendments, makes SB 7066 palatable to cannabis legalization supporters.
Tomorrow, May 8, 2014, in Portland, Oregon, the eighth annual Patients Out of Time Conference will begin through May 10, 2014. The focus of this year’s conference is on The Endocannabinoid System and Age Related Illness which is designed to attract a wider audience of those interested in learning more about cannabis as medicine. Attendees can earn CME and CLE credits and there is a chance for attending remotely.
The Florida Senate took up and passed SB 1030 Compassionate Medical Cannabis Act of 2014 on the final day of session, May 2, 2014. The House voted on an amended version on Thursday that raised the number of licenses to five; expands the disorders to include cancer; requires the dispensing organization to post a substantial bond; requires dispensing organizations to have a medical director with cannabinoid education to oversee the processing and dispensing and much more. Florida Governor Rick Scott has said he will sign the legislation into law.
Read the rest of the story here.